(Stroke. 2000;31:1294.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology, Royal Melbourne Hospital (J.J.), and Department of Pathology, University of Melbourne (C.A.M.), Parkville, Victoria, Australia; and The Baker Medical Research Institute (C.M.R.); Department of Pathology, New Academic Hospital (D.D.); Department of Nuclear Medicine, Medical University of Southern Africa (W.P.); Department of Chemical Pathology, University of Pretoria (R.D.); Vista University (L.S.); and the South African Institute of Medical Research (A.R.P.W.), South Africa.
Correspondence to Dr Jacques Joubert, Department of Neurology, Royal Melbourne Hospital, Grattan Street, Parkville, Victoria, Australia 3050. E-mail joubert{at}hotkey.net.au
| Abstract |
|---|
|
|
|---|
MethodsThe prevalence of CAD was determined by indicators identified through a series of 5 observational studies in black patients diagnosed with stroke. CAD indicators included (1) bedside diagnosis in 741 patients; (2) resting ECG in 555 consecutively admitted patients; (3) a combination of clinical examination, cardiac ultrasound, radionuclide scintigraphy, and multigated blood pool studies in 102 consecutively admitted patients; (4) thallium scintigraphy in 60 patients; and (5) necropsy in 23 patients.
ResultsOn bedside questioning, only 0.7% complained of previous angina. There was no history given of myocardial infarction (MI), but documentation of this was found in the clinical notes of 0.7% of the patients. In the resting ECG study, evidence of myocardial ischemia was present in 14.6% and MI in 2.1%. In the combined study, cardiac ischemia was documented on ECG in 12.7% of patients and evidence of previous MI in 5.8%. Cardiac scintigraphic studies revealed changes of myocardial ischemia in 31.7% and MI in 13.3% of the 60 patients studied. Four (17.4%) of 23 patients in the necropsy study had histological evidence of previous MI, and 50% of all patients had evidence of >50% atherosclerotic stenosis in 1, 2, or 3 coronary arteries.
ConclusionsThe prevalence of CAD in black African stroke patients is significantly higher than has been documented in the general nonstroke black population as well as in stroke patients. Black stroke patients may have a risk for CAD similar to that of their white counterparts.
Key Words: blacks cerebrovascular disorders coronary artery disease South Africa
| Introduction |
|---|
|
|
|---|
In western populations, there is accumulating evidence that asymptomatic CAD is common in patients with ischemic cerebrovascular disease.13 14 15 In fact, in one longitudinal study more than half the patients who survived an ischemic stroke subsequently died of MI.13
A significant association with asymptomatic CAD has been demonstrated in patients with both extracranial and intracranial carotid artery stenosis.16 17 A direct relationship has been reported between both the degree and the angiographic features of carotid artery disease and the severity of CAD and iliac stenosis in all age groups for men as well as older women.18 Atheroma of the carotid artery appears to be a marker for atherosclerosis in both coronary and peripheral limb vessels. Moreover, western patients with CT evidence of cerebral ischemia but who are asymptomatic for coronary heart disease have significantly more abnormal radionuclide myocardial perfusion defects than do nonstroke controls.15 19 20 21 It would therefore appear that in western populations, patients with ischemic cerebrovascular disease are at particular risk for CAD.20
The aim of the current study was to assess the prevalence of ischemic heart disease in South African black stroke patients through a variety of methods, ranging from bedside evaluation to cardiac scintigraphy and, finally, necropsy studies.
| Subjects and Methods |
|---|
|
|
|---|
Diagnosis of Stroke
Stroke was defined as rapidly developing signs of focal or
global disturbance of cerebral function leading to death or
lasting >24 hours with no apparent cause other than vascular.
Transient ischemic attacks (TIAs) were defined as deficits
lasting <24 hours.
The primary diagnostic categories of strokeTIAs, cerebral infarction, and parenchymal cerebral hemorrhagewere made on the basis of CT appearances, clinical guess, or autopsy evidence. In the stroke data bank as a whole, 73% of patients underwent CT scanning. For all patients, the final diagnosis of stroke and its subtype was made by the treating neurologist (J.J.).
Study Design
The study design was observational and consisted of a series of
5 separate sequential studies that evaluated the prevalence of CAD by a
variety of different investigative modalities (see the
Table
). For the most part, the patients were consecutive
admissions to the stroke database, but in the scintigraphic study
patients were randomized according to a computer-generated
randomization schedule. The necropsy study was on consecutive patients
who had been admitted to the MSDB and who died while in hospital.
Although it would have been ideal to have performed all the studies on
the same groups of patients, this was not possible due to practical
considerations. The groups were very similar with respect to age, sex,
and stroke pathology.
|
Historical Data
In this prospective study, symptoms of chest pain suggestive of
MI were assessed according to the London School of Hygiene Rose
questionnaire22 in all patients who were entered into the
MSDB. Two interviewers who were fluent in the local black languages
(Pedi, Tswana, and Zulu) were trained to administer the questionnaire.
They questioned the patients directly if they were able to give a
history, or the patients relatives or friends if they were unable to
do so. The clinical notes were studied for documentation of previous
historical or ECG evidence of CAD. The historical data of all patients
who had symptoms suggestive of myocardial ischemia were checked
by the first author (J.J.), who is fluent in the local black
languages.
ECG Study
An evaluation of the 12-lead resting ECGs of 555 stroke patients
who were consecutively admitted to the MSDB was made by 2 readers
blinded to both cardiovascular and stroke pathology of
the patients. Using the Minnesota coding system,23
attention was given to the presence of poor R wave progression in the
precordial leads, pathological Q waves (defined as Q waves
present in 2 contiguous leads,
25% of the R wave in the same
lead and of 0.04 seconds duration), and ST-T wave changes, such as flat
depression
1 mm below the baseline.
Combined Clinical, ECG, Cardiac Ultrasound, and Nuclear
Medicine Study
An additional 102 consecutively admitted stroke patients were
examined clinically by a cardiologist and underwent a resting ECG,
chest radiograph, cardiac ultrasound examination, and multigated blood
pool scan (MUGA). A final diagnosis of ischemic heart disease
was made by the cardiologist on the basis of all of the available
data.
Scintigraphic Study
Myocardial perfusion studies (methoxyisobutylisonitrile
or thallium) were performed on 60 randomly selected stroke patients
admitted to the data bank. Exclusion criteria were age <20 years;
moribund or very ill patients; and recognized contraindications for
provocative tests for myocardial ischemia, such as
asthma, severe hepatic dysfunction, and known allergy to
dipyridamole. Each myocardial perfusion study was
reviewed independently by 2 observers blinded as to the clinical
details. If there was disagreement in the interpretation, arbitration
was sought from a third observer. All of the studies were performed
with and without dipyridamole stress testing, as
opposed to exercise stress testing. Images were documented as
either (1) normal, with no perfusion defect before or after
dipyridamole stressing; (2) ischemic,
demonstrating a perfusion defect after dipyridamole
stressing, with the defect spontaneously reversing after a 4-hour
delay, or (3) infarction, ie, demonstrating an irreversible
perfusion defect present both before and after
dipyridamole stressing. In abnormal scans, the location
of the perfusion defects (inferior wall, anterior wall,
apex, and septum) and an arbitrary estimation of size according to the
number of segments involved (small: involving 1 segment; moderate: 2 or
3 segments; and large: involving
4 segments) was documented.
Necropsy Study
We performed macroscopic and microscopic pathological
examinations of the hearts, coronary vessels, and kidneys of 23
consecutive stroke patients dying in hospital after being admitted to
the MSDB. The hearts were examined for evidence of infarction, with
fibrosis being considered significant for MI at a measurement of
1 cm
in diameter. The entire dissected length of each major coronary
artery was transsected and the maximum area of stenosis
determined. The number of vessels showing >50% stenosis was
recorded, as were evidence of renal hypertensive changes and left
ventricular hypertrophy.
Consent and Institutional Review Procedures
The data for the historical and ECG studies were obtained as
part of the general medical workup of all stroke patients admitted to
the hospital. Therefore, consent was not sought from each patient
individually. Institutional review was obtained, however, for the
ongoing Medunsa Stroke Data Base, a project that began in 1983 and
ended in 1993.
Ethics approval was obtained for all the other studies (combined clinical, ECG, echocardiographic, and MUGA study; the scintigraphic study; and the autopsy study). Individual patient approval was obtained for the combined clinical, ECG, echocardiographic, and MUGA study, and for the scintigraphic study. Consent for the autopsy study was obtained from the relatives of the deceased.
| Results |
|---|
|
|
|---|
|
History of Angina or Previous Myocardial Infarction
Of the total of 984 patients entered into the MSDB between
1984 and 1993, the historical data of 741 were considered adequate for
the evaluation in mind. There were 526 patients (71%) with cerebral
infarction and 215 (29%) with parenchymal cerebral hemorrhage.
There were no patients with a history of TIA. A history compatible with
angina was present in 0.7% of the patients. No patient was aware
of having had a previous myocardial infarction (MI). However, according
to the medical records, 5 patients (0.7%) had previously
documented MI. No patient was aware of the distinction between cardiac
ischemia and other cardiac disease.
Electrocardiographic(ECG) Study
In the group of 555 consecutive stroke patients admitted to
the MSDB who were studied with resting ECGs, 72% had CT-confirmed
cerebral infarction, 28% had CT-confirmed parenchymal
hemorrhage, and 3 had TIAs. All of the patients had a resting
ECG performed between the 3rd and the 5th day after the stroke. In the
555 patients, ECG changes compatible with myocardial ischemia
were present in 81 patients (14.6%). In this group there were 56
patients with cerebral infarction and 25 with parenchymal cerebral
hemorrhage. Pathological Q waves compatible with previous MI
were present in 8 patients (1.4%), 3 of whom had cerebral
infarction and 5 parenchymal cerebral hemorrhage. ECG changes
of acute MI were present in 4 patients (0.7%); all of these
patients had CT evidence of cerebral infarction. Of the 555 ECGs
evaluated, changes considered to be indicative of CAD were present
in 16.8%.
Combined Study of 102 Patients (Clinical Assessment,
Radiographic, ECG, Cardiac Ultrasound Examination, and
MUGA).
There were 45 men and 57 women. The mean age of the male patients
was 55 years and that of the females 60 years (range 18 to 100 years).
All patients had CT scans of the brain. Cerebral hemorrhage was
observed in 22 patients, and the diagnosis of cerebral infarction was
made in 80.
In this group, 13 (12.7%) patients had T-wave or ST-segment changes on the ECG compatible with myocardial ischemia. Four patients had ECG evidence of old transmural MI. In 2 additional patients the ECG was negative, but the cardiac ultrasound revealed focal dyskinetic segments compatible with previous MI. A final diagnosis of previous MI was therefore made in 6 patients (5.8%). When the echocardiogram contributed to the diagnosis of previous MI by demonstrating segmental hypokinesis, the MUGA confirmed these findings. The average age of patients with evidence of MI was 68 years (range 56 to 82 years). No patient had evidence of recent MI, and none had a history of previous MI or of chest pain.
Scintigraphic Study
Of the 60 patients (30 men and 30 women), the average time
between stroke and scintigraphic study was 4 weeks. Their mean age was
53 years (range 24 to 94 years). Cerebral infarction was diagnosed on
CT scan in 53 patients (88.3%) and parenchymal
intracerebral hemorrhage in 7 (11.7%). There
were no patients with TIAs. Thirty-four patients (56.7%) had normal
myocardial perfusion imaging before and after
dipyridamole. Reversible perfusion defects
(ischemia) were present in 19 (31.7%), and fixed perfusion
defects (MI) were recorded in 8 (13.3%). CAD was therefore
diagnosed scintigraphically in a total of 27 patients (45%).
The mean age of the patients with MI was 53 years, compared with that of the patients with myocardial ischemia (52 years) and those with normal scintigrams (46 years).
Six patients with evidence of MI had perfusion defects of the inferior wall. This was taken into account in the assessment of the scintigraphs to differentiate between true perfusion defects and the "normal" attenuation seen in the proximity of the diaphragm. The majority of the abnormal scintigrams had only small perfusion defects; only 8 had "moderate" sized defects (3 in patients with MI), and none had "large" defects.
ECG evidence of ischemia was present in only half of the patients with myocardial ischemia on scintigraphy and in 1 patient with MI, the latter possibly because the majority of fixed perfusion defects observed on scintigraphy were inferiorly located.
Necropsy Study
The stroke pathology in the 23 patients was cerebral infarction
(in 16 patients) and parenchymal cerebral hemorrhage (in 7
patients). Although no patient had a history of previous MI, necropsy
evidence of previous MI was observed in 4 patients (17.4%). Fifty
percent of all of the patients had stenosis of >50% in 1, 2,
or 3 coronary vessels. Of all the patients (n=23), 21.7% had
stenosis of >70% in 1 vessel, 4.3% had 2-vessel
stenosis >70%, and 4.3% had 3 vessels with stenosis
>70%. The most frequently involved vessels were the left main
coronary artery (n=5) and the left anterior descending
coronary artery (n=7). Pathological findings consistent
with systemic hypertension were found in 52% of the patient group as a
whole, slightly less than those with a known documented history of
hypertension (71%). All 4 patients with MI were diabetic.
| Discussion |
|---|
|
|
|---|
1 of the coronary arteries in over half of all
necropsy patients examined, and 17.4% had histological
evidence of previous MI. There was good correlation between the
necropsy findings and those of the scintigraphic study group, with
13.3% of the latter having evidence of previous MI in the form of
irreversible perfusion defects. The prevalence of CAD (myocardial ischemic changes and/or frank infarction) in the 555 consecutive patients whose resting ECGs were analyzed was higher than that previously reported in studies on stroke and nonstroke populations of black Africans.2 9 11 24 25 26 The prevalence was similar to that found in a white nonstroke population in Durban, South Africa,27 and is comparable to the prevalence of CAD documented in stroke registries in Western populations.21 28 29
The ECG diagnosis of CAD in African blacks has been controversial since 1954, when Grusin30 reported that "ischemic" ECG variants were not indicative of CAD in this population. Later studies in both South African and Caribbean blacks confirmed these findings31 32 and led to certain local workers ignoring the ECG findings of "ischemia" in South African blacks and relying solely on a history of chest pain for the diagnosis of CAD.11 The danger of ascribing such ECG changes to a "normal variant pattern" in black Africans has been noted.33 In the nested study assessing clinical, ECG, ultrasound, MUGA evidence of CAD in 102 patients, the ECG prevalence of ischemic changes was found to be similar to that of the ECG study of 555 subjects; however, the adjunctive use of cardiac ultrasound and MUGA resulted in a 2-fold increase in detection of previous MI.
There is a significant difference between the prevalence of CAD in both the scintigraphic and necropsy studies of the stroke patients and the reported clinical experience reported in equatorial and Southern African countries, where evidence of CAD in the form of angina, or "events" such as MI, is still rare in the general black population as well as in stroke patients.1 2 3 4 5 11 24 25 26 For example, in King Edward VIII Hospital (2500 beds) in Durban, between 1955 and 1980 the diagnosis of CAD was made only in 2.7% of all Zulu patients admitted with cardiovascular disease compared with 30% in the case of Indian patients. In the same hospital, between 1980 and 1986, MI as the cause of death was documented in only 2.7% in 5000 consecutive nonstroke adult black necropsies.11 These data are in agreement with those of a general necropsy study of black (nonstroke) Africans made in Ghana, where the coronary vessels of the majority of patients, both normotensive and hypertensive, were found to be either normal or only minimally affected by atherosclerosis.34
In a comparison of age- and sex-specific mortality rates from CAD in interethnic populations in 1978 to 1989, a low mortality rate for ischemic heart disease in African blacks was reported.24 Similarly, in 1992, in an urban sample of 458 blacks (age range 16 to 69 years) the prevalence of CAD, assessed on the basis of anginal chest pain, was found to be only 2.4%.11 Thus, clinical CAD is very uncommon in urban South African blacks and "nearly absent" in their rural counterparts.25 In Soweto (population 3 to 4 million), at the Chris Hani Baragwanath Hospital (with 3200 beds, the largest hospital in the southern hemisphere), which caters almost exclusively to blacks, on average only about 70 patients with CAD are admitted annually.25 In the present study, a history of angina and/or a past history of MI were very uncommon, being present in <1% of patients. However, the historical evidence of CAD in the stroke patient may be misleading because of factors associated with the stroke itself.35 There was a relatively high prevalence of diabetes in our study in the patients with MI, as is also the case in the general population,36 so silent MI may be common.
This low prevalence of clinical CAD in African blacks prevails despite relatively major changes in both lifestyle and environmental exposure. Indeed, in a recent study of 1611 adult South African blacks, it was found that all the risk factors necessary for an "epidemic" of CAD were present.37
In sharp contrast to the foregoing, mortality rates for CAD among South African whites, Indians, and coloreds (EuropeanAfricanMalay South Africans of mixed ancestry) are among the highest in the western world.25 Furthermore, among African-Americans, CAD not only develops earlier but also, in the case of black women, carries a higher mortality rate than in white American women.38 Interestingly, blacks from both Africa and the Caribbean who migrate to the United Kingdom maintain a persistently low mortality rate from CAD compared with that of other migrant groups, for instance those from South Asia, which indicates a more complex multifactorial genesis for atherosclerosis than is apparent from known risk factors.39
Received November 1, 1999; revision received March 20, 2000; accepted March 20, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. H. Opie and Y. K. Seedat Hypertension in Sub-Saharan African Populations Circulation, December 6, 2005; 112(23): 3562 - 3568. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Joffe, L. A. Distiller, and W. J. Kalk Lipid Levels in Black South Africans With Type 2 Diabetes: Dispelling misconceptions Diabetes Care, July 1, 2004; 27(7): 1839 - 1840. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |